Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Clinical Microbiology Reviews

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1128/CMR.00006-09PMID 20375356PMCID PMC2863367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Posttransplant Lymphoproliferative Disorders

  2012cited by this paper
• EBV-Positive Diffuse Large B-Cell Lymphoma of the Elderly

  2012cited by this paper
• Viral-load and B-lymphocyte monitoring of EBV reactivation after allogeneic hemopoietic SCT in children

  2010cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary.

  2010cited by this paper
• Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients.

  2010cited by this paper
• Detection and quantitation of Epstein-Barr virus (EBV) DNA in EDTA whole blood samples using automated sample preparation and real time PCR

  2010cited by this paper
• Pediatric post-transplant lymphoproliferative disorder after cardiac transplantation

  2009cited by this paper
• The Impact of EBV Load on T-Cell Immunity in Pediatric Thoracic Transplant Recipients

  2009cited by this paper
• How I treat EBV lymphoproliferation.

  2009cited by this paper
• Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia

  2009influential reference
• Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.

  2009cited by this paper
• Preemptive Management of Epstein-Barr Virus Reactivation After Hematopoietic Stem-Cell Transplantation

  2009cited by this paper
• c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells

  2009cited by this paper
• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009cited by this paper
• Recommended principles and practices for validating clinical molecular pathology tests.

  2009influential reference
• Impact of valganciclovir on Epstein-Barr Virus polymerase chain reaction in pediatric liver transplantation: preliminary report.

  2009cited by this paper
• Gene expression using microarrays in transplant recipients at risk of EBV lymphoproliferation after organ transplantation: Preliminary proof‐of‐concept

  2009cited by this paper
• Increased Ig‐null B lymphocytes in the peripheral blood of pediatric solid organ transplant recipients with elevated Epstein‐Barr viral loads

  2009cited by this paper
• EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma.

  2009cited by this paper
• Post‐transplant lymphoproliferative disorder after pediatric liver transplantation: Characteristics and outcome

  2009cited by this paper
• Timing of Epstein-Barr Virus Acquisition and the Course of Posttransplantation Lymphoproliferative Disorder in Children

  2009cited by this paper
• Use of the Roche LightCycler 480 system in a routine laboratory setting for molecular diagnosis of opportunistic viral infections: Evaluation on whole blood specimens and proficiency panels.

  2009cited by this paper
• Treatment for Epstein-Barr virus-associated PTLD.

  2009cited by this paper
• Diagnosis and treatment of post‐transplantation lymphoproliferative disorder in pediatric heart transplant patients

  2009cited by this paper
• Epidemiology of Pretransplant EBV and CMV Serostatus in Relation to Posttransplant Non-Hodgkin Lymphoma

  2009cited by this paper
• Comparison of methods for extraction of viral DNA from cellular specimens.

  2009cited by this paper
• Associations of serum EBV DNA and gammopathy with post‐transplant lymphoproliferative disease

  2009cited by this paper
• Activation of the JAK/STAT Pathway in Epstein Barr Virus+‐Associated Posttransplant Lymphoproliferative Disease: Role of Interferon‐γ

  2009cited by this paper
• Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation.

  2009cited by this paper
• Role of EBV in microRNA dysregulation in Burkitt lymphoma.

  2009cited by this paper
• Significant risk factors for occurrence of cancer after renal transplantation: a single center cohort study of 1265 cases.

  2009cited by this paper
• Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.

  2009cited by this paper
• The role of valacyclovir on Epstein-Barr virus viral loads in pediatric liver transplantation patients.

  2009cited by this paper
• Epstein-Barr virus latent membrane protein 2A exploits Notch1 to alter B-cell identity in vivo.

  2009cited by this paper
• Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.

  2009cited by this paper
• Chronic high Epstein–Barr viral load carriage in pediatric small bowel transplant recipients

  2009cited by this paper
• Chronic high Epstein‐Barr viral load carriage in pediatric liver transplant recipients

  2009cited by this paper
• Standardisation of nucleic acid amplification assays used in clinical diagnostics: a report of the first meeting of the SoGAT Clinical Diagnostics Working Group.

  2009cited by this paper
• Targeted monitoring of patients at high risk of post‐transplant lymphoproliferative disease by quantitative Epstein–Barr virus polymerase chain reaction

  2009cited by this paper
• Reactivation of DNA viruses in association with histone deacetylase inhibitor therapy: a case series report

  2009cited by this paper
• Outcome of treatment of Epstein–Barr virus‐related post‐transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases

  2009cited by this paper
• Interlaboratory Comparison of Epstein‐Barr Virus Viral Load Assays

  2009influential reference
• Epstein–Barr virus LMP2A accelerates MYC-induced lymphomagenesis

  2009cited by this paper
• Growth-Promoting Properties of Epstein-Barr Virus EBER-1 RNA Correlate with Ribosomal Protein L22 Binding

  2009cited by this paper
• Evaluation of the Epstein-Barr virus R-gene quantification kit in whole blood with different extraction methods and PCR platforms.

  2008cited by this paper
• High Levels of Epstein-Barr Virus DNA in Latently Infected Gastric Adenocarcinoma

  2008cited by this paper
• Detection of specific lytic and latent transcripts can help to predict the status of Epstein-Barr virus infection in transplant recipients with high virus load.

  2008cited by this paper
• Epstein-Barr Virus BART MicroRNAs Are Produced from a Large Intron prior to Splicing

  2008cited by this paper
• EBV transformation overrides gene expression patterns of B cell differentiation stages.

  2008cited by this paper
• Effect of Epstein-Barr Virus Sequence Variation on Performance of the Roche Real-Time LightCycler PCR Assay

  2008cited by this paper
• Current understanding of the role of Epstein–Barr virus in lymphomagenesis and therapeutic approaches to EBV-associated lymphomas

  2008cited by this paper
• Incidence of PTLD in Pediatric Renal Transplant Recipients Receiving Basiliximab, Calcineurin Inhibitor, Sirolimus and Steroids

  2008cited by this paper
• Generation of Epstein-Barr virus-specific cytotoxic T lymphocytes resistant to the immunosuppressive drug tacrolimus (FK506).

  2008cited by this paper
• Molecular and Immunologic Mechanisms of Cancer Pathogenesis in Solid Organ Transplant Recipients

  2008cited by this paper
• Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

  2008influential reference
• Clinical significance of peripheral blood Epstein–Barr viral load monitoring using polymerase chain reaction in renal transplant recipients

  2008cited by this paper
• Measuring Epstein–Barr virus (EBV) load: the significance and application for each EBV‐associated disease

  2008cited by this paper
• EBV PCR in the Diagnosis and Monitoring of Posttransplant Lymphoproliferative Disorder: Results of a Two‐Arm Prospective Trial

  2008influential reference
• Epstein–Barr virus-associated lymphoproliferative disease after allogeneic haematopoietic stem cell transplantation: molecular monitoring and early treatment of high-risk patients

  2008cited by this paper
• Comparison of two highly automated DNA extraction systems for quantifying Epstein-Barr virus in whole blood.

  2008cited by this paper
• EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT

  2008cited by this paper
• Validation of an Epstein-Barr viral load assay using the QIAGEN Artus EBV TM PCR analyte-specific reagent.

  2008cited by this paper
• Monitoring of Epstein-Barr virus load and killer T cells in pediatric renal transplant recipients.

  2008cited by this paper
• Chronic High Epstein‐Barr Viral Load State and Risk for Late‐Onset Posttransplant Lymphoproliferative Disease/Lymphoma in Children

  2008cited by this paper
• Repertoire and frequency of immune cells reactive to Epstein-Barr virus-derived autologous lymphoblastoid cell lines.

  2008cited by this paper
• Laboratory assays for Epstein-Barr virus-related disease.

  2008influential reference
• A new prognosticator for post‐transplant lymphoproliferative disorders after renal transplantation

  2008cited by this paper
• Cancer incidence and survival in kidney transplant patients.

  2008cited by this paper
• Quantitative Epstein-Barr virus viral load monitoring in pediatric liver transplantation.

  2008cited by this paper
• Genetic and phenotypic analysis of B‐cell post‐transplant lymphoproliferative disorders provides insights into disease biology

  2008cited by this paper
• Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood.

  2008cited by this paper
• Anchor-based fluorescent amplicon generation assays (FLAG) for real-time measurement of human cytomegalovirus, Epstein-Barr virus, and varicella-zoster virus viral loads.

  2008cited by this paper
• Tumor-derived Variants of Epstein-Barr Virus Latent Membrane Protein 1 Induce Sustained Erk Activation and c-Fos*

  2008cited by this paper
• Two Epstein–Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma

  2008cited by this paper
• Epstein‐Barr virus load in whole blood is associated with immunosuppression, but not with post‐transplant lymphoproliferative disease in stable adult heart transplant patients

  2008cited by this paper
• Herpesvirus prevalence and viral load in healthy blood donors by quantitative real‐time polymerase chain reaction

  2008cited by this paper
• EBV-Negative Post-Transplant Lymphoproliferative Disorder (PTLD): A Retrospective Case-Control Study of Clinical and Pathological Characteristics, Response to Treatment and Survival

  2008cited by this paper
• Cell origin of pyothorax-associated lymphoma: a lymphoma strongly associated with Epstein–Barr virus infection

  2008cited by this paper
• Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.

  2008cited by this paper
• Optimization of an RNA isolation procedure from plasma samples.

  2007cited by this paper
• Short, discontinuous exposure to butyrate effectively sensitizes latently EBV-infected lymphoma cells to nucleoside analogue antiviral agents.

  2007cited by this paper
• Gene Expression Profiling of Epstein-Barr Virus-positive and -negative Monomorphic B-cell Posttransplant Lymphoproliferative Disorders

  2007cited by this paper
• Sustained Epstein‐Barr virus detection in paediatric liver transplantation. Insights into the occurrence of late PTLD

  2007cited by this paper
• Epstein‐Barr Virus: Evasive Maneuvers in the Development of PTLD

  2007cited by this paper
• Comparison of commercial and in-house Real-time PCR assays for quantification of Epstein-Barr virus (EBV) DNA in plasma

  2007cited by this paper
• The management of posttransplant lymphoproliferative disorder

  2007cited by this paper
• Epstein-Barr Virus–DNA Load Monitoring Late After Lung Transplantation: A Surrogate Marker of the Degree of Immunosuppression and a Safe Guide to Reduce Immunosuppression

  2007cited by this paper
• Structural variability of the carboxy‐terminus of Epstein–Barr virus encoded latent membrane protein 1 gene in Hodgkin's lymphomas

  2007cited by this paper
• Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial.

  2007cited by this paper
• Cytogenetic analysis of B-cell posttransplant lymphoproliferations validates the World Health Organization classification and suggests inclusion of florid follicular hyperplasia as a precursor lesion.

  2007influential reference
• Simultaneous Quantification of Epstein-Barr Virus, Cytomegalovirus, and Human Herpesvirus 6 DNA in Samples from Transplant Recipients by Multiplex Real-Time PCR Assay

  2007cited by this paper
• Multicenter Comparison of Different Real-Time PCR Assays for Quantitative Detection of Epstein-Barr Virus

  2007influential reference
• Subclinical cytomegalovirus and Epstein–Barr virus viremia are associated with adverse outcomes in pediatric renal transplantation

  2007cited by this paper
• A phase 1/2 trial of arginine butyrate and ganciclovir in patients with Epstein-Barr virus-associated lymphoid malignancies.

  2007cited by this paper
• Epstein–Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFβ signaling pathways

  2007cited by this paper
• Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis.

  2007cited by this paper
• T-cell and NK-cell posttransplantation lymphoproliferative disorders.

  2007cited by this paper
• Association of transforming growth factor-β1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases

  2007cited by this paper
• Presentation and early detection of post‐transplant lymphoproliferative disorder after solid organ transplantation

  2007cited by this paper
• Epstein-Barr viral load and disease prediction in a large cohort of allogeneic stem cell transplant recipients.

  2007cited by this paper

• Pediatric lymphoproliferative disorders – Emerging insights and management: A narrative review

  2026cites this paper
• Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab

  2025cites this paper
• Model Systems of Gammaherpesvirus Infection, Immunity, and Disease

  2025cites this paper
• A Rare Case of Post-Transplant Lymphoproliferative Disorder Presenting as Hodgkin Lymphoma After Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review

  2025cites this paper
• EBV+ polymorphic B-cell lymphoproliferative disorder, NOS: a single-center study of a newly recognized pathologic entity

  2025cites this paper
• Actionable Genes and Carcinogenic Pathways for Gastric Cancer in Latinos

  2025influential citation
• Development of a Diagnostic Algorithm for Epstein‐Barr Virus‐Related Diseases: A Retrospective Observational Study

  2025cites this paper
• Design and Development of a Multiplex Real-Time PCR Method for the Detection of Herpes Family Viruses in Transplant Patients

  2025cites this paper
• Incidence and Timing of Epstein–Barr Virus Whole Blood DNAemia in Epstein–Barr Virus‐Mismatched Adult and Pediatric Solid Organ Transplant Recipients

  2025cites this paper
• The diagnostic value of soluble Epstein-Barr Virus BZLF1 protein (sZEBRA) in the Detection of Post-transplant lymphoproliferative Disease (PTLD) among Solid Organ (SOT) and Haematopoietic Cell (HSCT) Transplant Recipients.

  2025cites this paper
• Mechanistic Understanding of EBV+Lymphoproliferative Disease Development After Transplantation

  2024cites this paper
• Performance of the cobas EBV and cobas BKV assays: multi-site comparison of standardized quantitation

  2024influential citation
• Internationally standardized respiratory viral load testing with limited resources: A derivative‐of‐care calibration strategy for SARS‐CoV‐2

  2024cites this paper
• A model of lymphocryptovirus-associated post-transplant lymphoproliferative disorder in immunosuppressed Mauritian cynomolgus macaques

  2024cites this paper
• Limited utility of Epstein-Barr virus (EBV) surveillance for predicting post-transplant lymphoproliferative disorders in adult EBV seropositive lung transplant recipients.

  2024cites this paper
• Nutrition and Epstein-Barr viremia in children underwent liver transplantation: A retrospective, cross-sectional study.

  2024cites this paper
• Experience with Epstein barr virus and Cytomegalovirus infection in Pediatric Liver Transplant Recipients: a 2014-2017 study

  2024cites this paper
• Clinical utility of EBV DNA testing of blood in immunocompetent and immunocompromised patients: A single-center experience.

  2024cites this paper
• A Multiplex Fluorescence of Loop Primer Upon Self-Dequenching Loop-Mediated Isothermal Amplification Assay for the Detection of Epstein–Barr Virus and Human Parvovirus B19 in Clinical Transplant Samples

  2024cites this paper
• Single-Center Outcomes of Epstein–Barr Virus DNAemia in Adult Solid Organ Transplant Recipients

  2024cites this paper
• Evaluation of a Quantitative Dual-Target EBV DNA Test on a Fully Automated Molecular Testing System

  2023influential citation
• Viral load: We need a new look at an old problem?

  2023cites this paper
• Post‐transplant lymphoproliferative disease in children, adolescents, and young adults

  2023cites this paper
• Calibration of cell-free DNA measurements by next-generation sequencing.

  2023cites this paper
• Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults.

  2023cites this paper
• Prevention of Oncogenic Gammaherpesvirinae (EBV and HHV8) Associated Disease in Solid Organ Transplant Recipients

  2023cites this paper
• Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial.

  2023cites this paper
• Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study

  2022influential citation
• High Predictive Value of the Soluble ZEBRA Antigen (Epstein-Barr Virus Trans-Activator Zta) in Transplant Patients with PTLD

  2022influential citation
• A brief overview of the Epstein Barr virus and its association with Burkitt's lymphoma

  2022cites this paper
• Post-transplant lymphoproliferative disease after pediatric kidney transplant

  2022cites this paper
• 18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD).

  2021cites this paper
• Clinical features and treatment strategies for post-transplant and iatrogenic immunodeficiency-associated lymphoproliferative disorders.

  2021cites this paper
• Analysis of Post-Transplant Lymphoproliferative Disorder (PTLD) Outcomes with Epstein–Barr Virus (EBV) Assessments—A Single Tertiary Referral Center Experience and Review of Literature

  2021cites this paper
• EBV Predicts Post-Pediatric Heart Transplant Malignancy; Induction Therapy and Tacrolimus Don't.

  2021cites this paper
• Richter transformation heralded by EBV reactivation during ibrutinib therapy for chronic lymphocytic leukemia

  2021cites this paper
• EBV‐specific cytotoxic T lymphocytes for refractory EBV‐associated post‐transplant lymphoproliferative disorder in solid organ transplant recipients: a systematic review

  2021cites this paper
• Post‐transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1954 Transplants

  2021cites this paper
• Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of Syrian EBV-Positive Burkitt’s Lymphoma

  2021cites this paper
• Post- transplant Lymphoproliferative Disorders After Liver Transplantation: A Retrospective Cohort Study Including 1,954 Transplants

  2021cites this paper
• Epstein-Barr virus-associated lymphoproliferative disorders in immunosuppressed patients

  2021influential citation
• Lymphoproliferative disorder in a lung transplant recipient

  2020cites this paper
• Epstein Barr virus genotypes (EBV1/EBV2) in individuals with infectious mononucleosis in the metropolitan area of Belém, Brazil, between 2005 and 2016 CURRENT STATUS: POSTED

  2020cites this paper
• Recent Advances in Diagnostic Approaches for Epstein–Barr Virus

  2020cites this paper
• Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring

  2020cites this paper
• Infectious diseases

  2020cites this paper
• Viral opportunistic infections in Mauritian cynomolgus macaques undergoing allogeneic stem cell transplantation mirror human transplant infectious disease complications

  2020cites this paper
• Epstein Barr Virus Associated Lymphomas and Epithelia Cancers in Humans

  2020cites this paper
• Epstein Barr virus genotypes (EBV1/EBV2) in individuals with infectious mononucleosis in the metropolitan area of Belém, Brazil, between 2005 and 2016

  2020cites this paper
• GENE EBNA3C: TYPES OF INFECTION BY EBV (EBV1 and EBV2), CORRELATION WITH CLINICAL AND BIOCHEMICAL PARAMETERS (AST, ALT and GGT) IN INDIVIDUALS WITH INFECTIOUS MONONUCLEOSIS OF THE METROPOLITAN AREA OF BELÉM, PARÁ, IN THE PERIOD OF 2005-2016

  2019cites this paper
• Valganciclovir prophylaxis delays onset of EBV viremia in high-risk pediatric solid organ transplant recipients

  2019cites this paper
• Plasma Epstein-Barr Virus Load as an Early Biomarker and Prognostic Factor of Human Immunodeficiency Virus–related Lymphomas

  2019cites this paper
• Evaluation of the new Abbott Real-Time EBV assay: fully automated quantification of EBV in whole blood by targeting BLLF1.

  2019cites this paper
• Comparison of Clinical Features and Outcome of Pediatric Posttransplant Lymphoproliferative Disorder in Recipients of Small Bowel Allograft Versus Isolated Liver Transplantation

  2019cites this paper
• Methylation analysis of plasma DNA informs etiologies of Epstein-Barr virus-associated diseases

  2019cites this paper
• Evaluation of four commercial extraction-quantification systems to monitor EBV or CMV viral load in whole blood.

  2019cites this paper
• Epstein-Barr Virus Infection and Posttransplant Lymphoproliferative Disease

  2019cites this paper
• Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield

  2019cites this paper
• EBV Viral Loads in Diagnosis, Monitoring, and Response Assessment

  2019cites this paper
• Influence of the 1st International WHO EBV Standard on quantitation of Epstein-Barr virus viral load in serum samples

  2019cites this paper
• Evaluation of the Abbott RealTime quantitative CMV and EBV assays using the maxCycle protocol in a laboratory automation context.

  2019cites this paper
• Roles of Epstein-Barr virus viral load monitoring in the prediction of posttransplant lymphoproliferative disorder in pediatric liver transplantation.

  2019cites this paper
• Gene EBNA3C: Type of Infection by EBV (EBV1 and EBV2) Correlation With Clinical and Biochemical Parameters (AST, ALT and GGT) in Individuals With Infectious Mononucleosis in the Metropolitan Area of Belém, Pará, 2005-2016

  2019cites this paper
• Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice

  2019cites this paper
• Infection in Kidney Transplantation

  2018cites this paper
• Epstein–Barr Virus DNAemia and co-occurrence with cytomegalovirus DNAemia in postrenal transplant recipients from a tertiary care center

  2018cites this paper
• Molecular Monitoring of Viral Infections

  2018cites this paper
• Post‑transplant lymphoproliferative disorder in hematopoietic stem cell transplant patients: A single center retrospective study between 2005 and 2012.

  2018cites this paper
• Epstein-Barr Virus DNA Viral Loads: Is There a Correlation Between Paired Whole Blood and Plasma Collected from a Cohort of Pediatric Renal Transplant Patients?

  2018cites this paper
• Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update

  2018cites this paper
• Association of Epstein-Barr virus infection with allogeneic hematopoietic stem cell transplantation in patients in Portugal

  2018cites this paper
• Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

  2018cites this paper
• Epstein–Barr virus infection in children with renal transplantation: A single‐centre experience

  2018cites this paper
• Respiratory Tract Diseases That May Be Mistaken for Infection

  2018cites this paper
• Plasma EBV microRNAs in paediatric renal transplant recipients

  2018cites this paper
• Comparison of two commercial quantitative PCR assays for EBV DNA detection and their correlation with the first WHO International Standard for EBV

  2018cites this paper
• Primary Intestinal Epstein–Barr Virus-associated Natural Killer/T-cell Lymphoproliferative Disorder: A Disease Mimicking Inflammatory Bowel Disease

  2018cites this paper
• Standardization of Viral Load Determination for Monitoring CMV, EBV, and BK Viruses in Solid Organ Transplant Recipients

  2018cites this paper
• Precision Molecular Pathology of Hodgkin Lymphoma

  2018cites this paper
• The Epidemiology of Hodgkin Lymphoma

  2018cites this paper
• INVESTIGATION OF IMMUNOSUPPRESSED PATIENTS FOR THE PRESENCE OF EBV DNA IN REAL TIME PCR

  2018cites this paper
• Risk factors, diagnosis, and management of posttransplant lymphoproliferative disorder: improving patient outcomes with a multidisciplinary treatment approach

  2017cites this paper
• Comparison of the artus Epstein-Barr virus (EBV) PCR kit and the Abbott RealTime EBV assay for measuring plasma EBV DNA loads in allogeneic stem cell transplant recipients.

  2017cites this paper
• CD56-Negative Aggressive NK Cell Leukemia Relapsing as Multiple Cranial Nerve Palsies: Case Report and Literature Review

  2017cites this paper
• Prognostic role of plasma Epstein-Barr virus DNA load for nasopharyngeal carcinoma: a meta-analysis.

  2017cites this paper
• Comparison of two automated instruments for Epstein-Barr virus serology in a large adult hospital and implementation of an Epstein-Barr virus nuclear antigen-based testing algorithm.

  2017cites this paper
• The impact of targeting repetitive BamHI-W sequences on the sensitivity and precision of EBV DNA quantification

  2017cites this paper
• Epstein‐Barr viral loads do not predict post‐transplant lymphoproliferative disorder in pediatric lung transplant recipients: A multicenter prospective cohort study

  2017cites this paper
• Lytic EBV infection investigated by detection of Soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD

  2017cites this paper
• Epstein-Barr virus DNA load kinetics analysis in allogeneic hematopoietic stem cell transplant recipients: Is it of any clinical usefulness?

  2017cites this paper
• Sero-Prevalence and Plasma Viral Load of Epstein Barr Virus among Iraqi Blood Donors

  2017cites this paper
• Peripheral Blood Epstein–Barr Viral Nucleic Acid Surveillance as a Marker for Posttransplant Cancer Risk

  2017cites this paper
• Molecular Testing for Herpes Viruses

  2017cites this paper
• EBV and MS: Major cause, minor contribution or red-herring?

  2017cites this paper
• The Epstein–Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells

  2017cites this paper
• [Clinical and morphological signs of viral damage to a kidney transplant].

  2017cites this paper
• Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation.

  2017cites this paper
• Post-transplant lymphoproliferative disorders

  2016cites this paper
• Seroprevalence and phylogenetic genotyping of Epstein Barr virus (EBV) among blood donors in Qatar

  2016cites this paper
• Automated Nucleic Acid Extraction Systems for Detecting Cytomegalovirus and Epstein-Barr Virus Using Real-Time PCR: A Comparison Study Between the QIAsymphony RGQ and QIAcube Systems

  2016cites this paper